Incretin class drugs are associated with the most favorable CGM-based outcomes among glucose-lowering medications for type 2 ...

A new study from the University of Virginia reveals that a widely used class of weight-loss drugs does more than suppress appetite-it directly alters brain circuits that control motivation and reward.

Older adults with type 2 diabetes face a difficult trade-off: they are among the most vulnerable to medication-related harms ...